Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Cancer Recurrent × Temozolomide × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Small Cell Lung Carcinoma 10 Lung Neoplasms 10 Neoplasm Metastasis 6 Brain Neoplasms 6 Melanoma 2 Breast Neoplasms 2 Adenocarcinoma of Lung 2 Small Cell Lung Cancer Recurrent 1 Sarcoma 1 SCLC, Extensive Stage 1 Recurrent Extensive Stage Small Cell Lung Carcinoma 1 Non Small Cell Lung Cancer Metastatic 1 Neuroendocrine Tumors 1 Neoplasms, Second Primary 1 Mesothelioma 1 Extensive Stage Small Cell Lung Cancer 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Neuroendocrine 1 Carcinoma, Large Cell 1 Carcinoma 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma 1

Interventions

atezolizumab 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02477813 2018-11-13

TeRes

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Small Cell Lung Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡